Showing results (211-220 of 261) with videos related to

Sort By:
Pageof 27
Frontiers in Medicine|March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registryAndreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
Clinical and Experimental Rheumatology|July 27, 2022
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitisCaterina Vacchi, Sofia Testoni, Marcella Visentini, et al.
Respiration; International Review of Thoracic Diseases|March 28, 2018
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary FibrosisSergio Harari, Antonella Caminati, Venerino Poletti, et al.
Clinical Rheumatology|August 20, 2013
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics registerFlorenzo Iannone, Elisa Gremese, Gaia Gallo, et al.
Respiration; International Review of Thoracic Diseases|September 13, 2021
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up StudyPaola Faverio, Fabrizio Luppi, Paola Rebora, et al.
RMD Open|April 28, 2025
Multicentre retrospective detection of nailfold videocapillaroscopy abnormalities in long covid patientsEmanuele Gotelli, Rosanna Campitiello, Carmen Pizzorni, et al.
The Journal of Rheumatology|February 1, 2026
Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: Insights From an Italian Multicenter CohortMarco Fornaro, Donato Lacedonia, Lorenzo Cavagna, et al.
Clinical Rheumatology|July 16, 2016
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function abilityFlorenzo Iannone, Lugi Sinigaglia, Ennio Giulio Favalli, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registriesVeronica Codullo, Florenzo Iannone, Luigi Sinigaglia, et al.
Respiratory Medicine|May 16, 2017
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung diseaseJulie Morisset, Eric Vittinghoff, Bo Young Lee, et al.
Pageof 27